oestrogen

DRUG2 trials

Sponsors

University of Aarhus, Novo Nordisk A/S

Conditions

Genetic DisorderHypopituitarismTurner Syndrome

Phase 4

Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome

CompletedNCT01518062

Novo Nordisk A/SGenetic Disorder, Turner Syndrome

Start: 1989-11-30End: 2003-09-30Updated: 2017-01-18

Unknown Phase

Oestrogen Withdrawal in Hypopituitary Women

CompletedNCT00572390

University of AarhusHypopituitarism

Start: 2001-01-31End: 2002-02-28Updated: 2007-12-13